A Sequential, Open Label Study to Compare the Pharmacokinetics, Safety and Tolerability of Ticagrelor and Venlafaxine Given Concomitantly in Healthy Subjects Aged 18 to 45 Years.
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2014
At a glance
- Drugs Ticagrelor (Primary) ; Venlafaxine
- Indications Acute coronary syndromes; Embolism and thrombosis; Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 29 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.